Clinical Trial Update: Use of Hypochlorous Acid as Prophylaxis in Health Personnel at High Risk of Infection by SARS-CoV 2 (COVID19) [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating hypochlorous acid prophylaxis for health personnel at high risk of SARS-CoV-2 infection has been withdrawn during Phase 2/Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov Infection

Snippet

Sponsor: Hospital Universitario San Ignacio | Conditions: SARS-CoV Infection, Covid19 | Phase 2, Phase 3 | Status: WITHDRAWN